ProQR Therapeutics NV (PRQR)
2.01
+0.02
(+1.00%)
USD |
NASDAQ |
May 03, 16:00
2.02
+0.01
(+0.50%)
After-Hours: 20:00
ProQR Therapeutics Profit Margin (Quarterly): -167.0% for Dec. 31, 2023
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -167.0% |
| September 30, 2023 | -416.8% |
| June 30, 2023 | -663.3% |
| March 31, 2023 | -1.36K% |
| December 31, 2022 | -1.85K% |
| September 30, 2022 | -2.86K% |
| Date | Value |
|---|---|
| June 30, 2022 | -1.47K% |
| March 31, 2022 | -1.25K% |
| December 31, 2021 | -7.88K% |
| September 30, 2021 | -1.73K% |
| June 30, 2021 | -6.48K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-7.88K%
Minimum
Dec 2021
-167.0%
Maximum
Dec 2023
-2.38K%
Average
-1.47K%
Median
Jun 2022
Profit Margin (Quarterly) Benchmarks
| uniQure NV | -1.09K% |
| Merus NV | -672.9% |
| argenx SE | -24.38% |
| Pharming Group | -3.85% |
| Pharvaris NV | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -53.15% |
| Return on Assets | -18.56% |
| Return on Invested Capital | -47.86% |
| Operating Margin (Quarterly) | -280.1% |
| Return on Net Operating Assets | -45.65% |